1. Autophagy and apoptosis: where do they meet?
   Subhadip Mukhopadhyay et al, 2014, Apoptosis CrossRef
2. Reoxygenation speed and its implication for cellular injury responses in hypoxic RAW 264.7 cells
   Jae Hyuk Lee et al, 2018, Journal of Surgical Research CrossRef
3. Novel zinc‑ and silicon‑phthalocyanines as photosensitizers for photodynamic therapy of cholangiocarcinoma
   Jacob Schmidt et al, 2018, International Journal of Molecular Medicine CrossRef
4. Autophagy as a potential therapeutic target during epithelial to mesenchymal transition in renal cell carcinoma: An in vitro study
   Mamta Singla et al, 2017, Biomedicine & Pharmacotherapy CrossRef
5. PI3K‐PKB‐mTOR hyperactivation in relation to nasopharyngeal carcinoma progression and prognosis
   Jian‐Hua Yu et al, 2019, Journal of Cellular Biochemistry CrossRef
6. Combining Neratinib with CDK4/6, mTOR, and MEK Inhibitors in Models of HER2-positive Cancer
   Ming Zhao et al, 2021, Clinical Cancer Research CrossRef
7. Clinical relevance of autophagic therapy in cancer: Investigating the current trends, challenges, and future prospects
   Subhadip Mukhopadhyay et al, 2016, Critical Reviews in Clinical Laboratory Sciences CrossRef
8. Modeling nasopharyngeal carcinoma in three dimensions
   Prabu Siva Sankar et al, 2017, Oncology Letters CrossRef
9. Pathogenesis of pediatric B‑cell acute lymphoblastic leukemia: Molecular pathways and disease treatments (Review)
   Fang‑Liang Huang et al, 2020, Oncology Letters CrossRef
10. Everolimus (RAD001) combined with programmed death-1 (PD-1) blockade enhances radiosensitivity of cervical cancer and programmed death-ligand 1 (PD-L1) expression by blocking the phosphoinositide 3-kinase (PI3K)/protein kinase B (AKT)/mammalian target of rapamycin (mTOR)/S6 kinase 1 (S6K1) pathway
    Lili Song et al, 2022, Bioengineered CrossRef
11. Niclosamide suppresses T‑cell acute lymphoblastic leukemia growth through activation of apoptosis and autophagy
    Fang-Liang Huang et al, 2021, Oncology Reports CrossRef
12. Synergic Effect of Metformin and Everolimus on Mitochondrial Dynamics of Renal Cell Carcinoma
    Seong-Hwi Hong et al, 2022, Genes CrossRef
13. mTOR inhibitors in urinary bladder cancer
    R. Pinto-Leite et al, 2016, Tumor Biology CrossRef
14. CD109 Promotes Drug Resistance in A2780 Ovarian Cancer Cells by Regulating the STAT3-NOTCH1 Signaling Axis
    Jun Se Kim et al, 2023, International Journal of Molecular Sciences CrossRef
15. Preclinical evaluation of the dual mTORC1/2 inhibitor sapanisertib in combination with cisplatin in nasopharyngeal carcinoma
    Jianbin Zhang et al, 2022, European Journal of Pharmacology CrossRef
16. Novel therapy for nasopharyngeal carcinoma – Where are we
    Janice Tsang et al, 2014, Oral Oncology CrossRef
17. The role of autophagy in squamous cell carcinoma of the head and neck
    Benjamin Cosway et al, 2016, Oral Oncology CrossRef
18. Small biomarkers with massive impacts: PI3K/AKT/mTOR signalling and microRNA crosstalk regulate nasopharyngeal carcinoma
    Hai-Long LI et al, 2022, Biomarker Research CrossRef
19. Hydroxychloroquine Destabilizes Phospho-S6 in Human Renal Carcinoma Cells
    Hyung-Ok Lee et al, 2015, PLOS ONE CrossRef
20. Everolimus downregulates estrogen receptor and induces autophagy in aromatase inhibitor-resistant breast cancer cells
    Asona Lui et al, 2016, BMC Cancer CrossRef